Recent study shows oral semaglutide reduces cardiovascular risk in type 2 diabetes patients, enhancing diabetes and heart ...

Did you know people with diabetes are twice as likely to develop heart disease compared to those without diabetes?

Heart disease is the leading cause of death among women, yet many miss the early warning signs due to subtle or atypical ...

Cardiovascular diseases (CVDs) remain the leading cause of mortality and disability in India, contributing to 31.8% of deaths. Noncommunicable diseases (NCDs), including CVDs, account for 60% ...

THE silent epidemic of hypertension and cardiovascular diseases in women, particularly in South Asia and Pakistan, ...

Once considered obscure or opportunistic, invasive fungal infections are now surfacing with alarming frequency - and in ...

Expanding obesity treatment access could generate $10 trillion for the country by boosting productivity, cutting healthcare ...

The Department of Health (DOH) on Friday reminded the public of the health hazards of tobacco and vapes, saying their use is ...

Proponents of coverage argued treating obesity can reduce longer-term costs by cutting down on heart attacks and other health ...

Sugary beverages, like soda, are the top source of added sugar in the U.S. diet. Drinking a can of soda daily may cut 12 ...

Diabetes patients on dulaglutide (Trulicity) had better glycemic control and more weight loss if they switched to tirzepatide (Mounjaro) rather than increasing the dose of the earlier-generation GLP-1 ...

World Kidney Day (WKD) 2025 was commemorated on March 13. It is a global campaign aimed at raising awareness of the importance of our kidneys. World Kidney Day returns every year.